Free Malaysia Today Pharmaniaga completes regularisation plan, to exit PN17 early 2026
This follows the completion of a capital reduction exercise, which involved the cancellation of RM520 million in issued share capital.
This follows the completion of a capital reduction exercise, which involved the cancellation of RM520 million in issued share capital.